Advertisement

Surgery Today

, 39:652 | Cite as

Indications for thyroid cancer surgery in elderly patients

  • Hiroshi Matsuyama
  • Iwao Sugitani
  • Yoshihide Fujimoto
  • Kazuyoshi Kawabata
Original Article

Abstract

Purpose

To define the indications for thyroid cancer surgery in elderly patients.

Methods

We compared the clinical characteristics of thyroid cancers in 85 elderly patients, defined as those aged ≥75 years, with those of 37 young patients, defined as those aged <30 years. The elderly group included patients who underwent surgery and/or reoperation and those managed nonoperatively. All patients were treated during an 11-year period from 1994 to 2004 at the Cancer Institute Hospital.

Results

The elderly patients with papillary thyroid carcinoma had a significantly worse cumulative 5-year survival rate than the young patients with papillary thyroid carcinoma (92% vs 100%: P = 0.03). However, there was no significant difference in the survival of patients with low-risk tumors between the two age groups. The cumulative 2-year survival rate of elderly patients with a high-risk tumor was significantly lower in patients not treated with surgery than in those treated surgically (80% vs 100%: P = 0.02). Quality of life (QOL) was severely impaired in 67% and 6% of the nonoperated and operated patients, respectively.

Conclusions

These results suggest that surgery for thyroid cancer increases the survival rate and promotes the QOL of elderly patients if they are well enough to tolerate the procedure.

Key words

Thyroid cancer Elderly Surgical indications Quality of life 

References

  1. 1.
    Cady B. Presidential address: Beyond risk groups — a new look at differentiated thyroid cancer. Surgery 1998;124:947–957.PubMedGoogle Scholar
  2. 2.
    Biliotti GC, Martini F, Vezzosi V, Seghi P, Tozzi F, Castagnoli A, et al. Specific features of differentiated thyroid carcinoma in patients over 70 years of age. J Surg Oncol 2006;93:194–198.CrossRefPubMedGoogle Scholar
  3. 3.
    Nakayama H, Wada N, Masudo Y, Rino Y. Axillary lymph node metastasis from papillary thyroid carcinoma: report of a case. Surg Today 2007;37:311–315.CrossRefPubMedGoogle Scholar
  4. 4.
    Shaha AR. TNM classification of thyroid carcinoma. World J Surg 2007;31:879–887.CrossRefPubMedGoogle Scholar
  5. 5.
    Wada N, Nakayama H, Suganuma N, Masudo Y, Rino Y, Masuda M, et al. Prognostic value of the sixth edition AJCC/UICC TNM classification for differentiated thyroid carcinoma with extrathyroid extension. J Clin Endocrinol Metab 2007;92:215–218.CrossRefPubMedGoogle Scholar
  6. 6.
    Yamada H, Miyamura T, Fuke T, Tomioka T. Definition of “elderly patients” with thyroid cancer based on high risk cancer (in Japanese). Jpn J Head Neck Cancer 2006;32:168Google Scholar
  7. 7.
    Sugitani I., Kawabata K. New classification system for extrathyroidal invasion of thyroid papillary carcinoma (in Japanese). Jpn J Head Neck Cancer 2006;32:510–514.Google Scholar
  8. 8.
    Sugitani I, Kasai N, Fujimoto Y, Yanagisawa A. A novel classification system for patients with PTC: addition of the new variables of large (3cm or greater) nodal metastases and reclassification during the follow-up period. Surgery 2004;135:139–148.CrossRefPubMedGoogle Scholar
  9. 9.
    Cady B, Rossi R. An expanded view of risk group definition in differentiated thyroid carcinoma. Surgery 1988;104:947–953.PubMedGoogle Scholar
  10. 10.
    Laura E, Cady B. Differentiated thyroid cancer: Reexamination of risk groups and outcome of treatment. Arch Surg 1998;133:419–425.CrossRefGoogle Scholar
  11. 11.
    Hay ID, Grant CS, Taylor WF, McConahey WM. Ipsilateral lobectomy versus bilateral lober resection in papillary thyroid carcinoma: a retrospective analysis of surgical outcome using a novel prognostic scoring system. Surgery 1987;102:1088–1095.PubMedGoogle Scholar
  12. 12.
    Hay ID, Bergstralh EJ, Goellner JR, Ebersold JR, Grant CS. Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 1993;114:1050–1058.PubMedGoogle Scholar
  13. 13.
    Jukkola A, Bloigu R, Ebeling T, Salmela P, Blanco G. Prognostic factors in differentiated thyroid carcinomas and their implications for current staging classifications. Endocr Relat Cancer 2004;11:571–579.CrossRefPubMedGoogle Scholar
  14. 14.
    Voutilainen PE, Siironen P, Franssila KO, Sivula A, Haapiainen RK, Haglund CH. AMES, MACIS and TNM prognostic classifications in papillary thyroid carcinoma. Anticancer Res 2003;23:4283–4288.PubMedGoogle Scholar
  15. 15.
    Lin JD, Chao TC, Chen ST, Weng HF, Lin KD. Characteristics of thyroid carcinomas in aging patients. Eur J Clin Invest 2000;30:147–153.CrossRefPubMedGoogle Scholar
  16. 16.
    Vini L, Hyer SL, Marshall J, A’Hern R, Harmer C. Long-term results in elderly patients with differentiated thyroid carcinoma. Cancer 2003;97:2736–2742.CrossRefPubMedGoogle Scholar
  17. 17.
    Vassilopoulou-Sellin R, Schultz PN, Haynie TP. Clinical outcome of patients with papillary thyroid carcinoma who have recurrence after initial radioactive iodine therapy. Cancer 1996;78:493–501.CrossRefPubMedGoogle Scholar
  18. 18.
    Patel KN, Shaha AR. Locally advanced thyroid cancer. Curr Opin Otolaryngol Head Neck Surg 2005;13:112–116.CrossRefPubMedGoogle Scholar
  19. 19.
    Kuijpens JL, Janssen-Heijnen ML, Lemmens VE, Haak HR, Heijckmann AC, Coebergh JW. Comorbidity in newly diagnosed thyroid cancer patients: a population-based study on prevalence and the impact on treatment and survival. Clin Endocrinol 2006;64:450–455.CrossRefGoogle Scholar
  20. 20.
    Uruno T, Miyauchi A, Shimizu K, Tomoda C, Takamura Y, Ito Y, et al. Favorable Surgical Results in 433 Elderly Patients with Papillary Thyroid Cancer. World J Surg 2005;29:1497–1501.CrossRefPubMedGoogle Scholar
  21. 21.
    Ardito G, Revelli L, Tosti F, Modugno P, Giacinto O, Praquin B, et al. Surgery of differentiated thyroid carcinoma, lymph node metastases and locoregional recurrence. Rays 2000;25:199–206.PubMedGoogle Scholar
  22. 22.
    Fujimoto Y, Obara T, Ito Y, Kodama T, Yashiro T, Yamashita T, et al. Aggressive surgical approach for locally invasive papillary carcinoma of the thyroid in patients over forty-five years of age. Surgery 1986;100:1098–1107.PubMedGoogle Scholar
  23. 23.
    Kloos RT. Papillary thyroid cancer: medical management and follow-up. Curr Treat Options Oncol 2005;6:323–338.CrossRefPubMedGoogle Scholar
  24. 24.
    Pagano L, Klain M, Pulcrano M, Angellotti G, Pasano F, Salvatore M, et al. Follow-up of differentiated thyroid carcinoma. Minerva Endocrinol 2004;29:161–174.PubMedGoogle Scholar
  25. 25.
    Pacini F. Follow-up of differentiated thyroid cancer. Eur J Nucl Med Mol Imaging 2002;29:492–496.Google Scholar
  26. 26.
    Kuriakose MA, Hicks WL Jr, Loree TR, Yee H. Risk groupbased management of differentiated thyroid carcinoma. J R Coll Surg Edinb 2001;46:216–223.PubMedGoogle Scholar

Copyright information

© Springer 2009

Authors and Affiliations

  • Hiroshi Matsuyama
    • 1
  • Iwao Sugitani
    • 2
  • Yoshihide Fujimoto
    • 2
  • Kazuyoshi Kawabata
    • 2
  1. 1.Department of OtolaryngologyNiigata University Faculty of MedicineNiigataJapan
  2. 2.Department of Head and NeckCancer Institute HospitalTokyoJapan

Personalised recommendations